Skip to main content

Lifestyle Risk Reduction

0
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Shield Therapeutics
Shield TherapeuticsMA - Wellesley
1 program
Intensive Lifestyle interventionN/A1 trial
Active Trials
NCT05554705Terminated114Est. Jan 2023
Jerusalem Pharmaceuticals
Jerusalem PharmaceuticalsIsrael - Ramallah
1 program
Lay-led FL workshopsN/A1 trial
Active Trials
NCT06258733Not Yet Recruiting480Est. Feb 2027

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
Jerusalem PharmaceuticalsLay-led FL workshops
Shield TherapeuticsIntensive Lifestyle intervention

Clinical Trials (2)

Total enrollment: 594 patients across 2 trials

Food Literacy Intervention - is a "Train the Trainer" Approach Feasible and Effective?

Start: Dec 2025Est. completion: Feb 2027480 patients
N/ANot Yet Recruiting
NCT05554705Shield TherapeuticsIntensive Lifestyle intervention

Lifestyle Intervention for Rheumatoid Arthritis

Start: Jan 2023Est. completion: Jan 2023114 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.